Latest Breaking News On - Helen parry - Page 15 : comparemela.com
Retrasar la segunda dosis aumenta la inmunización
misionesonline.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from misionesonline.net Daily Mail and Mail on Sunday newspapers.
Coronavirus: retrasar la segunda dosis de la vacuna aumenta la inmunización
ellitoral.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ellitoral.com.ar Daily Mail and Mail on Sunday newspapers.
A health-care professional prepares a dose of the Pfizer coronavirus disease (COVID-19) vaccine as high-risk workers receive the first vaccines in the state of Victoria s rollout of the program, in Melbourne, Australia, Feb. 22, 2021. Photo by SANDRA SANDERS /REUTERS
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page.
Article content
LONDON Pfizer’s COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said.
The study released on Friday is the first to directly compare immune responses of the Pfizer shot from the three-week dosing interval tested in clinical trials, and the extended 12-week interval that British officials recommend in order to give more vulnerable people at least some protection quickly.
Delay in getting 2nd shot of Pfizer COVID-19 vaccine produces more antibodies: UK study
Our study demonstrates that peak antibody responses after the second Pfizer vaccine are markedly enhanced in older people when this is delayed to 12 weeks, Helen Parry, an author of the study based at the University of Birmingham, said
Reuters | May 14, 2021 | Updated 11:12 IST
Pfizer s COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said.
The study released on Friday is the first to directly compare immune responses of the Pfizer shot from the three-week dosing interval tested in clinical trials, and the extended 12-week interval that British officials recommend in order to give more vulnerable people at least some protection quickly.
vimarsana © 2020. All Rights Reserved.